| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9941028 | American Journal of Hypertension | 2005 | 6 Pages |
Abstract
In the absence of major cardiovascular risk factors, nondipper essential hypertensive patients show more prominent insulin resistance and lower adiponectin compared to dippers. Therapeutic modulation of adiponectin or insulin resistance might provide additional benefit to the conventional antihypertensive treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paolo Della Mea, Mario Lupia, Valentina Bandolin, Samuele Guzzon, Nicoletta Sonino, Roberto Vettor, Francesco Fallo,